StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$3.17+0.51 (+19.17%)

Close on Nov 18, 2026Market cap $117.87MP/E –Yield –

Armata Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2014 it was $409.00K, up 404.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2014Dec 31, 2014$409.00K+404.9%
FY2013Dec 31, 2013$81.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020$31.00K–

More Armata Pharmaceuticals figures

See a number that looks wrong?